Fintel reports that on October 8, 2025, Evercore ISI Group maintained coverage of Quest Diagnostics (NYSE:DGX) with a In-Line ...
In the latest quarter, 7 analysts provided ratings for Quest Diagnostics (NYSE: DGX ), showcasing a mix of bullish and ...
Evercore ISI raised the firm’s price target on Quest Diagnostics (DGX) to $190 from $185 and keeps an In Line rating on the shares as the firm ...
The Animal Auto-Immune Disease Diagnostics Market is witnessing significant growth, estimated at USD 6.2 billion in 2025 and ...